Facebook users around the world are having trouble with the platform.
A global outage is impacting Instagram and WhatsApp as well.
Complaints started surfacing around Noon Eastern.
Facebook says it’s working to fix the problem.
The provincial government is taking further action to protect long-term care residents.
Effective November 15, fully COVID vaccinations will be mandatory for all in-home staff, support workers, students and volunteers.
Minister responsible Rod Phillips says current vaccination rates aren’t high enough in the face of the risk posed by the Delta variant.
“Currently, 367 of the 626 homes have staff immunization levels below 90% and more concerningly 99 homes have a rate below 80%.”
The new requirements include:
-Staff who do not have all required doses or a valid medical exemption by the November 15 deadline will not be able to enter a long-term care home to work.
-Newly hired staff will be required to be fully vaccinated before they begin working in a home unless they have a valid medical exemption.
-Homes will begin randomly testing fully vaccinated individuals, including staff, caregivers and visitors, to help detect possible breakthrough cases of COVID-19 as soon as possible.
Other immediate provincial measures include:
-rigorous inspections to reinforce infection prevention and control
-regularly testing all individuals who are not fully vaccinated
-providing a COVID-19 vaccine promotion toolkit available in 12 languages
-organizing mobile clinics at homes with lower vaccination rates and homes experiencing outbreaks
-providing homes with support so they can administer vaccines themselves in a timely manner
-working to increase the hours of direct care for residents to an average of four hours per day by 2024-2025
-collecting more accurate vaccination data at the home level
-offering third doses to long-term care residents
Phillips notes as of September 30, 64% of residents have already received their third dose.
The COVID-19 pandemic dominated the Speech from the Throne.
Lieutenant Governor Elizabeth Dowdeswell read the speech this morning, which promised no new taxes.
“Unprecedented levels of spending have created new fiscal challenges,” read Dowdeswell.
“Your government remains steadfast in its commitment to an economic and a fiscal recovery that is fueled by economic growth and not painful tax hikes or spending cuts.”
The speech only promised one new piece of legislation aimed at improving care in the Long Term Care sector.
“This fall your government will also introduce legislation to protect residents through better accountability, enforcement, and transparency. The days when bad actors could get away with anything less than quality care for our most vulnerable will be over.”
The Speech from the Throne mainly focused on what the Ford government did and what it was doing to combat the pandemic, but there was little in the way of new programs the government was going to pursue leading up to the next election in June of 2022.
Advil Cold & Sinus Day/Night Convenience Pack is being recalled after a labeling error.
The specific batches that are being recalled are the convenience pack box of 36 caplets (lot number ER2072) and the convenience pack box of 18 caplets (lot number ER2069). Both batches have expiry dates of February 2023.
The labeling on the back of the pill package is misaligned labeling some nighttime pills as day time which can have adverse effects because of the anti-histamine in them.
“Taking a nighttime caplet when alertness is required may pose potentially serious adverse health consequences, such as when driving motor vehicles or operating heavy machinery. It may also cause potentially serious health consequences for those who have taken other sedatives or tranquilizers, consumed alcohol, and the elderly. The affected products were distributed in Canada starting July 2021.” This was in a statement on the recall with the Government of Canada’s website.
Auro Pharma Inc. is recalling seven lots of blood pressure drugs because of an impurity.
Certain lots of irbesartan, losartan and valsartan drugs have more than the allowed level of what’s called an azido impurity.
Health Canada says long-term exposure could increase the risk of cancer.
However, they say not to stop taking this medication unless your doctor tells you to, because it’s more dangerous to stop treating your condition than to possibly get small amounts of this impurity.
The agency says to talk to your healthcare provider about your treatment options, and report any side effects.
The recall was first announced in May, and has been expanded several times.
Affected products
The full list of products is listed alphabetically by name.
|
Product |
Company |
DIN |
Lot |
Expiry |
Date Added |
|
Irbesartan |
|||||
|
AVALIDE 150-12.5 mg TABLETS
|
sanofi-aventis Canada |
02241818 |
ET02879 |
June 2021 |
June 15, 2021 |
|
AVALIDE 150-12.5 mg TABLETS
|
sanofi-aventis Canada |
02241818 |
FT01327 |
December 2021 |
June 15, 2021 |
|
AVALIDE 300-12.5 mg TABLETS
|
sanofi-aventis Canada |
02241819 |
FT01644
|
February 2022 |
June 15, 2021 |
|
AVAPRO 75 mg TABLETS
|
sanofi-aventis Canada |
02237923 |
FT00590 |
October 2021 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS
|
sanofi-aventis Canada |
02237924 |
FT01238 |
January 2022 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS
|
sanofi-aventis Canada |
02237924 |
ET04153 |
August 2021 |
June 15, 2021 |
|
AVAPRO 150 mg TABLETS
|
sanofi-aventis Canada |
02237924 |
FT01995 |
March 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS
|
sanofi-aventis Canada |
02237925 |
FT00969 |
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS
|
sanofi-aventis Canada |
02237925 |
FT01225
|
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS
|
sanofi-aventis Canada |
02237925 |
FT01226
|
January 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS
|
sanofi-aventis Canada |
02237925 |
FT01999
|
March 2022 |
June 15, 2021 |
|
AVAPRO 300 mg TABLETS |
sanofi-aventis Canada |
02237925 |
FT04262
|
July 2022 |
June 15, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
617491 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
618112 |
March 2022 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
624632 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
624633 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 150 mg TABLETS |
Pro Doc Ltd. |
02365200 |
630546 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
615929 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
617091 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
617264 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
620694 |
March 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624189 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624190 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624191 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 300 mg TABLETS |
Pro Doc Ltd. |
02365219 |
624192 |
January 2023 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
616518 |
June 2021 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
619960 |
November 2021 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
622192 |
May 2022 |
May 30, 2021 |
|
IRBESARTAN 75 mg TABLETS |
Pro Doc Ltd. |
02365197 |
622193 |
December 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JN5054 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JV2163 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
JY7867 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
KT2519 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/150/12.5 mg |
Sivem Pharmaceuticals |
02385317 |
KT2520 |
May 2023 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JP2979 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JP2980 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JU8206 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/12.5 mg |
Sivem Pharmaceuticals |
02385325 |
JU8207 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JX8881 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JX8882 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN HCT/TABLET/300/25 mg |
Sivem Pharmaceuticals |
02385333 |
JB0216 |
May 2021 |
May 30, 2021 |
|
IRBESARTAN/TABLET/150 mg |
Sivem Pharmaceuticals |
02385295 |
KC7215 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN/TABLET/300 mg |
Sivem Pharmaceuticals |
02385309 |
KF8325 |
July 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JN4976 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JU3231 |
January 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 150/12.5 mg TABLETS |
Pro Doc Ltd. |
02365162 |
JY1913 |
June 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
HW0586 |
February 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
HW0587 |
February 2021 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JR7823 |
February 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JR7824 |
February 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pro Doc Ltd. |
02365170 |
JU7506 |
April 2022 |
May 30, 2021 |
|
IRBESARTAN-HCTZ 300/25 mg TABLETS |
Pro Doc Ltd. |
02365189 |
JS0731 |
February 2022 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 150/12.5 mg TABLETS |
Mint Pharmaceuticals Inc. |
02392992 |
1805011398 |
August 2021 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 300/12.5 mg TABLETS |
Mint Pharmaceuticals Inc. |
02393018 |
1805011402 |
August 2021 |
May 30, 2021 |
|
MINT- IRBESARTAN /HCTZ 300/25.0 mg TABLETS |
Mint Pharmaceuticals Inc. |
02393026 |
1805011576 |
August 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
617492 |
July 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
624634 |
January 2023 |
May 30, 2021 |
|
pms-IRBESARTAN 150 mg TABLETS |
Pharmascience Inc. |
02317079 |
630661 |
May 2023 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617466 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617467 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
617468 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
620272 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
622195 |
December 2022 |
May 30, 2021 |
|
pms-IRBESARTAN 75 mg TABLETS |
Pharmascience Inc. |
02317060 |
624738 |
December 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
621822 |
July 2021 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
621823 |
November 2021 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
625318 |
February 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
625902 |
January 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
629920 |
July 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
631052 |
October 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/12.5 mg TABLETS |
Pharmascience Inc. |
02328526 |
632583 |
November 2022 |
May 30, 2021 |
|
pms-IRBESARTAN-HCTZ 300/25 mg TABLETS |
Pharmascience Inc. |
02328534 |
624235 |
June 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47146 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47147 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB47148 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57691 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57688 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB57689 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
AB58827 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 150 mg |
Sun Pharma Canada Inc. |
02406829 |
3990655 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB47144 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB47145 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58305 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58304 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58312 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58314 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB58828 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB57696 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70496 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70498 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
AB70499 |
June 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
3991358 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 300 mg |
Sun Pharma Canada Inc. |
02406837 |
3991360 |
November 2021 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB47143 |
April 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB58473 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
AB58829 |
May 2023 |
May 30, 2021 |
|
RAN- IRBESARTAN Tablets 75 mg |
Sun Pharma Canada Inc. |
02406810 |
3994101 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN 150 mg TABLETS |
Sandoz Canada Inc. |
02328488 |
KC7216 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN 300 mg TABLETS |
Sandoz Canada Inc. |
02328496 |
KF8326 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JF5840 |
August 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4197 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4971 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JU3217 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JV2167 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JF8892 |
August 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 150/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337428 |
JN4191 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JA4033 |
February 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
HY7383 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JA4034 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JE2529 |
July 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JK7459 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JK7460 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM3516 |
October 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM3517 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JR7821 |
February 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7500 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7501 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7502 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JU7503 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JY0147 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JM4631 |
November 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/12.5 mg TABLETS |
Sandoz Canada Inc. |
02337436 |
JZ2686 |
April 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JB0221 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JB0222 |
May 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JC4402 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JC4404 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JH2487 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR7112 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR7833 |
January 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JU3181 |
February 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JW9512 |
May 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JW9513 |
May 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
KC1750 |
August 2022 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JE1833 |
June 2021 |
May 30, 2021 |
|
Sandoz IRBESARTAN HCT 300/25 mg TABLETS |
Sandoz Canada Inc. |
02337444 |
JR8726 |
January 2022 |
May 30, 2021 |
|
Losartan |
|||||
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020001A |
19 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020002A |
20 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg |
Auro Pharma Inc. |
02403358 |
AEJ1020003A |
21 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020001A |
16 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020002A |
17 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 50 mg |
Auro Pharma Inc. |
02403331 |
AEJ5020003A |
18 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 25 mg |
Auro Pharma Inc. |
02403323 |
AEJ2520001A |
19 December 2023 |
October 1, 2021 |
|
AURO-LOSARTAN 100 mg TABLETS |
Auro Pharma Inc. |
02403358 |
WB1019001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 100 mg TABLETS |
Auro Pharma Inc. |
02403358 |
WB1019001-B |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 25 mg TABLETS |
Auro Pharma Inc. |
02403323 |
WB2519001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 50 mg TABLETS |
Auro Pharma Inc. |
02403331 |
WB5019001-A |
14 August 2022 |
May 30, 2021 |
|
AURO-LOSARTAN 50 mg TABLETS |
Auro Pharma Inc. |
02403331 |
WB5019001-B |
14 August 2022 |
May 30, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
KS3239 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
KV8086 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 25 MG TABLETS |
Sanis Health Inc. |
02388863 |
LH0370 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KS1007 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KS8836 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
KY7469 |
06/2022 |
September 16, 2021 |
|
LOSARTAN 50 MG TABLETS |
Sanis Health Inc. |
02388871 |
LB2316 |
08/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
KS9031 |
02/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
KY5728 |
07/2022 |
September 16, 2021 |
|
LOSARTAN 100 MG TABLETS |
Sanis Health Inc. |
02388898 |
LJ2274 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
KS7557 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
KX6499 |
06/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 50/12.5MG TABLETS |
Sanis Health Inc. |
02427648 |
LB3650 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
KS9114 |
03/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
LB1656 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/12.5MG TABLETS |
Sanis Health Inc. |
02427656 |
LG7830 |
08/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KS3078 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KU3077 |
02/2022 |
September 16, 2021 |
|
LOSARTAN/HCT 100/25MG TABLETS |
Sanis Health Inc. |
02427664 |
KZ7521 |
06/2022 |
September 16, 2021 |
|
LOSARTAN /TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080620 |
June 2023 |
May 30, 2021 |
|
LOSARTAN /TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0090620 |
June 2023 |
May 30, 2021 |
|
LOSARTAN /TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2151119 |
November 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2101018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2020219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2030219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2040219 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2090619 |
June 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2100919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2110919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2120919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2130919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2050420 |
April 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2060420 |
April 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2070817 |
August 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2040218 |
February 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/100 mg |
Sivem Pharmaceuticals ULC |
02388812 |
2140919 |
September 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0050919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0060919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0070919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0080919A |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0101019 |
October 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0101019A |
October 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0030120 |
January 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/25 mg |
Sivem Pharmaceuticals ULC |
02388790 |
0040120 |
January 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1121018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1131018 |
October 2021 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1130819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1140819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1150819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1160819 |
August 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1180919 |
September 2022 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1070220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1080220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1090220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1100220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1110220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1060220 |
February 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1170919 |
September 2023 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1120620 |
June 2024 |
May 30, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1010419 |
April 2022 |
August 28, 2021 |
|
LOSARTAN/TABLET/50 mg |
Sivem Pharmaceuticals ULC |
02388804 |
1020419 |
April 2022 |
August 28, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KF3703 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KF3704 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KR0055 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KS3238 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KV8085 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 25 mg TABLETS |
Sandoz Canada Inc. |
02313332 |
KY3612 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KF3629 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS1008 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS1009 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KS8837 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KT8356 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc. |
02313340 |
KY7473 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc |
02313340 |
KS1006 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 50 mg TABLETS |
Sandoz Canada Inc |
02313340 |
KY7472 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KF3630 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KR6172 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KS7551 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LA1962 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LD1621 |
2022-08-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LJ2275 |
2022-08-31 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
KR6171 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN 100 mg TABLETS |
Sandoz Canada Inc |
02313359 |
LA0665 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KF3705 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KF3706 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KR8908 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS7564 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KX6497 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
LB3649 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KR7041 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS5626 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KS5627 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 50/12.5 mg TABLETS |
Sandoz Canada Inc |
02313375 |
KX6500 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KF3628 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3893 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KT2043 |
2022-03-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KY9842 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
LB1657 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KF3714 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3889 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KS3890 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KT2044 |
2022-03-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/12.5 mg TABLETS |
Sandoz Canada Inc |
02362449 |
KY9846 |
2022-07-31 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KG4858 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KU3078 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KS3076 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KZ7522 |
2022-06-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KG4859 |
2021-09-30 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KS3077 |
2022-02-28 |
September 16, 2021 |
|
Sandoz LOSARTAN HCT 100/25 mg TABLETS |
Sandoz Canada Inc |
02313383 |
KZ7520 |
2022-06-30 |
September 16, 2021 |
|
Teva-Losartan 100 mg tablets |
Teva Canada Ltd. |
02357976 |
2050419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets
|
Teva Canada Ltd. |
02357968 |
1070917 |
September 2021 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets |
Teva Canada Ltd. |
02357968 |
1020419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 50 mg tablets
|
Teva Canada Ltd. |
02357968 |
1030419 |
April 2022 |
August 28, 2021 |
|
Teva-Losartan 25 mg tablets
|
Teva Canada Ltd. |
02380838 |
0040917 |
September 2021 |
August 28, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2010219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2010420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2020219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2020420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2030420 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2040219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2060419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2080619 |
June 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2080918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2091018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2101018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2161119 |
November 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2171119 |
November 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2030218 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2070419 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2181119 |
November 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2191119 |
November 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 100 mg TABLETS |
Teva Canada Ltd. |
02357976 |
2140919 |
September 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0010219 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0020419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0030419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0031018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0040120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0040919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0050620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0050919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0060620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0070620 |
June 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0010120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 25 mg TABLETS |
Teva Canada Ltd. |
02380838 |
0020120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1040120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1030120 |
January 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1040419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1050419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1060419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1070419 |
April 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1080918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1090819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1090918 |
September 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1100819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1101018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1110819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1111018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1121018 |
October 2021 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1130819 |
August 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1180919 |
September 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1010120 |
January 2024 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1030218 |
February 2022 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1080419 |
April 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1120819 |
August 2023 |
May 30, 2021 |
|
TEVA-LOSARTAN 50 mg TABLETS |
Teva Canada Ltd. |
02357968 |
1141018 |
October 2022 |
May 30, 2021 |
|
Valsartan |
|||||
|
Sandoz Valsartan 160 mg TABLETS |
Sandoz Canada Inc. |
02356767 |
KT9598 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 320 mg TABLETS |
Sandoz Canada Inc. |
02356775 |
KT8923 |
April 2023 |
May 30, 2021 |
|
Sandoz Valsartan 320 mg TABLETS |
Sandoz Canada Inc. |
02356775 |
KV6185 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 80 mg TABLETS |
Sandoz Canada Inc. |
02356759 |
KT7180 |
March 2023 |
May 30, 2021 |
|
Sandoz Valsartan 80 mg TABLETS |
Sandoz Canada Inc. |
02356759 |
KT9515 |
April 2023 |
May 30, 2021 |
|
VALSARTAN 160 mg TABLETS |
Sanis Health Inc. |
02366967 |
KT9597 |
March 2023 |
May 30, 2021 |
One batch of the birth control pill Mirvala 28 recalled because of blister package errors.
The Government of Canada is recalling one batch of the birth control after a placebo pill (green pill) is in place of an active birth control pill (white).
This is a concern as the placebo pill has no active hormones to help protect against pregnancy and increases risk of a pregnancy because the pill does not contain any active hormone. It may also cause side effects, including spotting and irregular bleeding.
Area coaches, volunteers and officiators of indoor organized sports will soon have to be fully vaccinated against COVID-19.
Northern Ontario’s seven Medical Officers of Health, including Dr. Kit Young Hoon of the Northwestern Health Unit and Dr. Janet DeMille of the Thunder Bay District Health Unit, have issued instructions to facility operators under the Reopening Ontario Act to require those coaching, volunteering or officiating aged 12 and older to provide proof of vaccination or a valid medical exemption as of October 14.
“Vaccination is one way to protect people and allow these sports to continue,” explains Dr. Kit Young Hoon. “It was noted in the provincial regulations that were recently released that there were exceptions given for coaches, volunteers and officials and so that was felt to be a weakness in the legislation that needed to be addressed, so this is happening across the north.”
Health Officials say the new requirement comes as organized sports have the potential to increase risk COVID-19 transmission.
“You do have to exert more energy, more forced exhalation, it’s close contact definitely within two metres and often people are not wearing masks, plus it’s indoors,” continues Dr. Young Hoon.
Currently, Ontario requires proof of vaccination for all those 12 and older entering any indoor sport facility for spectating and recreational fitness facilities but exempts those aged 12 to 17 who are actively participating in organized sports.
However, the Northern Ontario Medical Officers of Health are continuing to monitor the local COVID-19 situation and adjust instructions as needed.
Now in the fourth wave of the pandemic, health officials are cautious of the highly transmissible Delta variant, the dominant strain, causing COVID-19 cases.
With all seven Northern Ontario public health units are implementing the same requirement, officials add this will also help reduce the risk of spread and keep communities safe when groups and teams travel.
Health Officials say everyone aged 12 and over is still strongly encouraged to get vaccinated as soon as possible.
Additionally, Municipalities, businesses and organizations across the region are strongly recommended to develop or may already have their own COVID-19 vaccination policies in place.
Expanding First Nation, Métis and Inuit content and learning in the elementary curriculum.
The Minister of Education Stephen Lecce made the announcement Wednesday along with the Minister of Indigenous Affairs Greg Rickford and Traditional Knowledge Keeper Vivian Roy at the Native Child and Family Services of Toronto.
This includes mandatory learning being added to the grade 1 to 3 social studies curriculums, focusing on topics such as:
It is being planned that this will be implemented into the curriculum by Sept. 2023.
Along with this, the ministry will be providing $23.96 million in Indigenous Education funding to support First Nations, Métis and Inuit students as part of a broader government commitment to reconciliation.
During the announcement Lecce stated that consultation was crucial in an undertaking such as this.
“Part of this is a recognition that there was a gap in the current compliment of learning, where grades one to three within our social science program did not have any learning related to Indigenous history, culture, contribution, and most specifically on residential schools,” explains Lecce. “Following the advice of Indigenous Leaders and Elders, and through a co-development process we’ve come to a decision point and we’ve been working with them for many months to be fair over 2021 to get to this place, to announce this formally, to take a step forward, both in context of language, in the strengthening of residential school learning, and the completion of learning between grade one and high school creating a continuum of learning, part of our commitment to reconciliation.”
Lecce goes on to say Ontario has requested that all school boards use Truth and Reconciliation Day to educate students on Indigenous contributions, along with the history of residential schools.
Ontario’s Regional Chief Glen Hare stated that he is very pleased with the announcement, and hopes to see continued efforts from the government.
“This will assist us in retaining the expertise required to ensure the educational priorities of First Nation communities are addressed in the provincial education system in a timely manner. We also look forward to establishing a robust and meaningful collaborative process with the Ministry of Education to ensure the experience and knowledge of First Nations in Ontario is accurately reflected throughout the province’s curriculum.”
This commitment falls in with Ontario’s Truth and Reconciliation Commission’s Calls to Action, which were implemented in 2018.
Currently, there is mandatory learning on residential schools in grades 8 and 10.
If you’ve been worrying your child may lose their ID when showing their COVID-19 vaccine passport, the province is trying to make things a little easier.
Ontario is now allowing youth aged 12 to 17 to show a photocopy or photo of their ID instead of the original alongside their proof of vaccination.
This only applies to youth, and all other age groups still need to show your original government-issue ID such as a driver’s license, citizenship card, birth certificate, passport, Status Card, health card, or permanent resident card.
Starting October 22nd, you won’t have to show ID if you download the province’s proof of vaccination app.
If you received two different COVID-19 vaccine doses, international travel may have to wait a while longer.
Canada’s chief public health officer Dr. Theresa Tam says officials are talking with other countries to see if they will recognize Canadians with mixed doses as being fully immunized.
Dr. Tam says while some European countries have already agreed because they also administered mixed doses, you should be sure before you book any travel.
“They must check in with the specific country requirements prior to travel because it is a bit of a varied landscape out there, but we are doing everything we can to facilitate that recognition,” she says.
If you want to head to the United States, Dr. Tam says right now main question is whether it will recognize AstraZeneca doses.
“We’ve been presenting our data, for example, on the vaccine effectiveness of the mixed dose schedule such as AstraZeneca followed by mRNA vaccines,” Dr. Tam explains.
The United States never approved AstraZeneca’s vaccine for use, so Canada has been providing its own figures that the U.S. can use to make its own decision.
AstraZeneca seems to be the current focus, as Dr. Tam underlines “The issue isn’t with the mRNA vaccines in terms of interchangeability.”
While she says talks are going well, the U.S. border is still closed to non-essential travel for Canadians.
